Order
Animal Models

Pxr-Car Knockout Mouse

 

C57BL/6 Background

Model Number Zygosity Nomenclature
8222-F Homozygous Deletion/Homozygous Deletion C57BL/6-Nr1i2tm3Arte Nr1i3tm1.1Arte
8222-M Homozygous Deletion/Homozygous Deletion C57BL/6-Nr1i2tm3Arte Nr1i3tm1.1Arte
  • Description
  • Health Reports/Production Sites

Model Description

    • This targeted mutation strain carries a deletion of the mouse Nr1i2 and Nr1i3 genes which encode for the nuclear receptors PXR and CAR.
    • Useful in defining the effect of PXR and CAR on CYP induction and therefore pharmacokinetics, drug toxicity and efficacy.
    • In conjunction with the Humanized PXR-CAR Mouse line (Taconic model number 8223), this model has relevance for the prediction of the hazard of non-genotoxic rodent liver growth carcinogens to humans.

Origin:
The Pxr-Car Knockout mouse was developed by TaconicArtemis in collaboration with CXR Biosciences. The double knockout model was generated by crossing each humanized single gene mouse line with a PhiC31 deleter mouse. The two single knockout lines were then crossed together. The Humanized PXR Mouse model was created through a knock in of a human PXR cDNA/genomic construct onto the ATG of murine Pxr in C57BL/6NTac-derived ES cells. The Humanized CAR Mouse model was created through a knock in of a human CAR construct containing the genomic sequence from the translational start site on exon 2 to exon 9 onto the ATG of murine CAR in C57BL/6NTac-derived ES cells. In both cases targeted ES cells were injected into BALB/cJBomTac blastocysts and the resultant chimeras were backcrossed to a Flpe deleter strain on C57BL/6J to eliminate selection markers. The Pxr Knockout Mouse model was derived from the Humanized PXR Mouse line through a PhiC31-mediated deletion of the human PXR sequence. Mouse exon 2, carrying the translational start site, is deleted in the knockout, while mouse exon 1 and exons 3-9 are still present. A splice acceptor polyA motif included in the targeting vector causes splicing of exon 1 to a polyA motif and thereby terminates the transcription. The absence of PXR protein was proven experimentally. The Car Knockout Mouse model was derived from the Humanized CAR Mouse line through a PhiC31-mediated deletion of the human CAR sequence. This deletes all exons coding for functional domains of CAR (exon 3-9). The absence of CAR protein was proven experimentally. The Pxr-Car Knockout Mouse line was obtained by crossing the single knockout mouse lines for both receptors. Taconic received stock in 2008, and the line was embryo transfer derived. The colony is maintained by mating double homozygotes.

Color: Black

Initial Publication: Scheer N, Ross J, Rode A, Zevnik B, Niehaves S, Faust N, Wolf CR. (2008) A novel panel of mouse models to evaluate the role of human pregnane X receptor and constitutive androstane receptor in drug response. J. Clin. Invest. 118(9): 3228-3239.

Animal Diet: NIH #31M Rodent Diet

Licensing Requirements:

Non-profit users (excluding users at non-profit foundations which are affiliated with a for-profit entity): Taconic Non-Profit MTA (PDF 32KB)

Pricing for non-profit users (excluding users at non-profit foundations which are affiliated with a for-profit entity):

8222

Age (weeks) Male or Female
4 to 8 $200.00

Pxr-Car Knockout Mouse European prices for non-profit users




For-profit users (including users at non-profit foundations which are affiliated with a for-profit entity): Taconic For-Profit MTA (PDF 28KB)

Pricing for for-profit users (including users at non-profit foundations which are affiliated with a for-profit entity):

8222

Age (weeks) Male or Female
4 to 8 $275.00

Pxr-Car Knockout Mouse European prices for for-profit users


Availability: Immediate availability of appropriately-sized cohorts.

Related Services
  • Contract research services using the Pxr-Car Double Knockout Mouse co-exclusively provided by CXR Biosciences
Customer Service Need additional help finding and ordering Taconic products and services?

Contact Us or call:

  • 888.TACONIC (822.6642)
  • Fax: 518.697.3910
  • +45 70 23 04 05 (Europe)